Skip to main content
Michael Lieberman, MD, Pathology, Houston, TX, Houston Methodist Hospital

MichaelWLiebermanMD

Pathology Houston, TX

Anatomic Pathology, Clinical Pathology

Physician

Are you Dr. Lieberman?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Connect with colleagues in the same hospital or clinic
    You already have 30 invites waiting!
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Summary

  • Dr. Michael Lieberman, MD is a board certified pathologist in Houston, Texas. He is currently licensed to practice medicine in Texas. He is affiliated with Houston Methodist Hospital.

Education & Training

  • UPMC Medical Education
    UPMC Medical EducationResidency, Pathology-Anatomic and Clinical, 1967 - 1969
  • University of Pittsburgh School of Medicine
    University of Pittsburgh School of MedicineClass of 1967

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 1989 - 2014
  • American Board of Pathology Anatomic Pathology

Publications & Presentations

PubMed

Grant Support

  • As-Gsh Conjugation Limits As Availability &ToxicityNational Institute Of Environmental Health Sciences2000–2004
  • Baylor College Of Medicine Cancer CenterNational Cancer Institute2003
  • Function Of Gamma Glutamyl LeukotrienaseNational Institute Of Environmental Health Sciences2001–2003
  • Response To Injury In Gammaglutamyl Cycle Deficient MiceNational Institute Of Environmental Health Sciences2000–2003
  • Metabolism In Gamma-Glutamy1 Transpeptidase Defict MiceNational Institute Of Environmental Health Sciences1997–2000
  • Responses To Injury In Gamma Glutamyl Cycle DeficientNational Institute Of Environmental Health Sciences1997–1999
  • Metabolism In And-Glutamyl Transpeptidase Deficient MiceNational Institute Of Environmental Health Sciences1996
  • Consequences Of Targetet Gene Expression To The ProstateNational Cancer Institute1992–1995
  • Carcinogen Activation Of Unexpressed Mammalian GenesNational Cancer Institute1989–1995
  • Carcinogen Activation Of Unexpressed GenesNational Cancer Institute1994
  • Molecular Pathology Of Transgenic Liver &Kidney CancerNational Cancer Institute1991–1993
  • Molecular Mechanisms Of Carcinogenesis ConferenceNational Cancer Institute1991
  • Metallothionein Activation--A Model Of Carcinogen ActionNational Cancer Institute1989–1991
  • Gene Expression In Carcinogen-Induced Liver CancerNational Cancer Institute1989–1990
  • Analysis Of Hepatocellular Carcinoma Development By NMR ImagingNational Cancer Institute1987–1989
  • Carcinogen Activation Of Unexpressed Mammalian GenesNational Cancer Institute1988
  • Gene Expression In Carcinogen-Induced Liver CancerNational Cancer Institute1985–1988
  • Carcinogen Activation Of Unexpressed Mammalian GenesNational Cancer Institute1985–1987

Hospital Affiliations